A research team at the University of Oxford has received funding to work on a potential ovarian cancer vaccine.
The vaccine, called OvarianVax, is being designed to train the immune system to detect and target the earliest signs of ovarian cancer. Over the next three years, Cancer Research UK will provide up to £600,000 to fund the project.
Professor Ahmed Ahmed, the director of the university's ovarian cancer cell laboratory, mentions that they still have "a long way to go" but he is "optimistic." The scientists will work on developing the vaccine in the lab with the goal of training the immune system to recognize proteins on the surface of ovarian cancer cells, known as tumour-associated antigens. After this initial phase, they will begin testing the vaccine on patients who have the disease.
"The idea is, if you give the vaccine, these tiny tumours will hopefully either reduce, shrink really significantly, or disappear," said Prof Ahmed.
In the following phase, the team intends to involve women who carry genetic mutations that heighten their risk of developing ovarian cancer, along with a wider group of women who do not have any known health issues, to assess the vaccine's potential to prevent the disease.
London hosted a giant multiplayer Tetris game to mark its 40th anniversary, inviting players to control pieces on LED screens in a free, interactive event at Outernet.
UK government has confirmed that disposable vapes will be banned from sale starting June 2025
Boris Johnson’s memoir "Unleashed" offers a mix of humour, controversy, and self-reflection. Packed with political drama, colourful anecdotes, and bold claims, the 772-page book highlights his years in office while hinting at possible future ambitions.
U.S. stocks dip as election nears, with Trump and Harris in a tight race and investors bracing for Fed policy news.
UN Deputy Secretary-General Amina Mohammed urged fair policies for clean energy minerals, highlighting the need for equity, transparency, and environmental protection as demand soars worldwide.
Retailers like Walmart are using advanced weather data to shape local promotions and inventory, adjusting prices on seasonal items like sunscreen and winter gear. New tools help companies plan amid unpredictable weather patterns driven by climate change.
AstraZeneca’s new weight-loss pill, AZD5004, shows promise in early trials with tolerable side effects, advancing to Phase II studies focused on reducing obesity.
Ryanair has trimmed its passenger growth target for the year ending March 2026 from 215 million to 210 million due to Boeing delivery delays. Despite a reported after-tax profit of 1.79 billion euros, average fares dropped by 10% this year.
Democratic presidential candidate Kamala Harris campaigns in Michigan on Sunday while her Republican rival Donald Trump stops in three eastern battleground states just two days before elections
Democratic candidate Kamala Harris and Republican Donald Trump remain in a tight race in the country's seven battleground states
AstraZeneca’s new weight-loss pill, AZD5004, shows promise in early trials with tolerable side effects, advancing to Phase II studies focused on reducing obesity.
An analysis of U.S. health claims reveals that while GLP-1 drugs like Wegovy may aid weight loss, they significantly increase medical costs—rising to $18,507 annually—without reducing obesity-related health events, raising concerns for insurers and employers.
The CDC confirms bird flu in two Washington poultry workers and ruled out infections in Missouri healthcare staff.
UK government has confirmed that disposable vapes will be banned from sale starting June 2025
Germany has detected its first case of the new mpox variant, clade 1b, in a 33-year-old man.
U.S. stocks dip as election nears, with Trump and Harris in a tight race and investors bracing for Fed policy news.
UN Deputy Secretary-General Amina Mohammed urged fair policies for clean energy minerals, highlighting the need for equity, transparency, and environmental protection as demand soars worldwide.
Retailers like Walmart are using advanced weather data to shape local promotions and inventory, adjusting prices on seasonal items like sunscreen and winter gear. New tools help companies plan amid unpredictable weather patterns driven by climate change.
AstraZeneca’s new weight-loss pill, AZD5004, shows promise in early trials with tolerable side effects, advancing to Phase II studies focused on reducing obesity.
Ryanair has trimmed its passenger growth target for the year ending March 2026 from 215 million to 210 million due to Boeing delivery delays. Despite a reported after-tax profit of 1.79 billion euros, average fares dropped by 10% this year.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment